• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为c-Jun氨基末端激酶-3(JNK3)抑制剂的(苯并噻唑-2-基)乙腈衍生物的三维定量构效关系(3D-QSAR)及对接研究

Three-dimensional quantitative structure-activity relationship (3 D-QSAR) and docking studies on (benzothiazole-2-yl) acetonitrile derivatives as c-Jun N-terminal kinase-3 (JNK3) inhibitors.

作者信息

Shaikh Abdul Rajjak, Ismael Mohamed, Del Carpio Carlos A, Tsuboi Hideyuki, Koyama Michihisa, Endou Akira, Kubo Momoji, Broclawik Ewa, Miyamoto Akira

机构信息

Department of Applied Chemistry, Graduate School of Engineering, Tohoku University, 6-6-11-1302 Aoba, Aramaki, Sendai 980-8579, Japan.

出版信息

Bioorg Med Chem Lett. 2006 Nov 15;16(22):5917-25. doi: 10.1016/j.bmcl.2006.06.039. Epub 2006 Sep 20.

DOI:10.1016/j.bmcl.2006.06.039
PMID:16989998
Abstract

Three-dimensional quantitative structure-activity relationship (3D-QSAR) models were developed for 44 (benzothiazole-2-yl) acetonitrile derivatives, inhibiting c-Jun N-terminal kinase-3 (JNK3). It includes molecular field analysis (MFA) and receptor surface analysis (RSA). The QSAR model was developed using 34 compounds and its predictive ability was assessed using a test set of 10 compounds. The predictive 3D-QSAR models have conventional r2 values of 0.849 and 0.766 for MFA and RSA, respectively; while the cross-validated coefficient r(cv)2 values of 0.616 and 0.605 for MFA and RSA, respectively. The results of the QSAR model were further compared with a structure-based analysis using docking studies with crystal structure of JNK3. Ligands bind in the ATP pocket and the hydrogen bond with GLN155 was found to be crucial for selectivity among other kinases. The results of 3D-QSAR and docking studies validate each other and hence, the combination of both methodologies provides a powerful tool directed to the design of novel and selective JNK3 inhibitors.

摘要

针对44种抑制c-Jun氨基末端激酶-3(JNK3)的(苯并噻唑-2-基)乙腈衍生物构建了三维定量构效关系(3D-QSAR)模型。该模型包括分子场分析(MFA)和受体表面分析(RSA)。使用34种化合物构建了QSAR模型,并使用10种化合物的测试集评估其预测能力。预测性3D-QSAR模型中,MFA和RSA的传统r2值分别为0.849和0.766;而MFA和RSA的交叉验证系数r(cv)2值分别为0.616和0.605。将QSAR模型的结果与基于结构的分析进行了进一步比较,该分析使用了JNK3晶体结构的对接研究。配体结合在ATP口袋中,并发现与GLN155的氢键对于区分其他激酶至关重要。3D-QSAR和对接研究的结果相互验证,因此,两种方法的结合为新型选择性JNK3抑制剂的设计提供了一个强大的工具。

相似文献

1
Three-dimensional quantitative structure-activity relationship (3 D-QSAR) and docking studies on (benzothiazole-2-yl) acetonitrile derivatives as c-Jun N-terminal kinase-3 (JNK3) inhibitors.作为c-Jun氨基末端激酶-3(JNK3)抑制剂的(苯并噻唑-2-基)乙腈衍生物的三维定量构效关系(3D-QSAR)及对接研究
Bioorg Med Chem Lett. 2006 Nov 15;16(22):5917-25. doi: 10.1016/j.bmcl.2006.06.039. Epub 2006 Sep 20.
2
Exploration of a binding mode of benzothiazol-2-yl acetonitrile pyrimidine core based derivatives as potent c-Jun N-terminal kinase-3 inhibitors and 3D-QSAR analyses.基于苯并噻唑-2-基乙腈嘧啶核心的衍生物作为有效的c-Jun氨基末端激酶-3抑制剂的结合模式探索及三维定量构效关系分析
J Chem Inf Model. 2006 Jul-Aug;46(4):1763-74. doi: 10.1021/ci060057q.
3
3D-QSAR studies of triazafluorenone inhibitors of metabotropic glutamate receptor subtype 1.代谢型谷氨酸受体亚型1的三氮杂芴酮抑制剂的3D-QSAR研究
Eur J Med Chem. 2008 May;43(5):1025-34. doi: 10.1016/j.ejmech.2007.06.024. Epub 2007 Jul 14.
4
3D-QSAR studies on chromone derivatives as HIV-1 protease inhibitors: application of molecular field analysis.作为HIV-1蛋白酶抑制剂的色酮衍生物的3D-QSAR研究:分子场分析的应用
Arch Pharm (Weinheim). 2008 Jun;341(6):357-64. doi: 10.1002/ardp.200700229.
5
3D-QSAR and molecular docking studies on benzothiazole derivatives as Candida albicans N-myristoyltransferase inhibitors.作为白色念珠菌N-肉豆蔻酰基转移酶抑制剂的苯并噻唑衍生物的3D-QSAR和分子对接研究
Eur J Med Chem. 2007 Apr;42(4):477-86. doi: 10.1016/j.ejmech.2006.11.001. Epub 2006 Nov 18.
6
Receptor-guided alignment-based comparative 3D-QSAR studies of benzylidene malonitrile tyrphostins as EGFR and HER-2 kinase inhibitors.基于受体引导比对的苄叉丙二腈酪氨酸磷酸化抑制剂作为表皮生长因子受体(EGFR)和人表皮生长因子受体2(HER-2)激酶抑制剂的3D-QSAR研究
J Med Chem. 2003 Oct 23;46(22):4657-68. doi: 10.1021/jm030065n.
7
3D-QSAR studies on c-Src kinase inhibitors and docking analyses of a potent dual kinase inhibitor of c-Src and c-Abl kinases.c-Src激酶抑制剂的3D-QSAR研究以及一种有效的c-Src和c-Abl激酶双重抑制剂的对接分析。
Bioorg Med Chem. 2005 Aug 1;13(15):4704-12. doi: 10.1016/j.bmc.2005.04.065.
8
3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments.蛋白质酪氨酸磷酸酶1B抑制剂的3D QSAR研究:基于不同构象比对获得的3D QSAR模型之间的质量和预测能力比较。
J Chem Inf Model. 2006 Nov-Dec;46(6):2579-90. doi: 10.1021/ci600224n.
9
Exploration of a binding mode of indole amide analogues as potent histone deacetylase inhibitors and 3D-QSAR analyses.吲哚酰胺类似物作为强效组蛋白脱乙酰酶抑制剂的结合模式探索及三维定量构效关系分析。
Bioorg Med Chem. 2005 Sep 15;13(18):5424-34. doi: 10.1016/j.bmc.2005.05.016.
10
3D-QSAR CoMFA, CoMSIA studies on substituted ureas as Raf-1 kinase inhibitors and its confirmation with structure-based studies.3D-QSAR CoMFA、CoMSIA对取代脲类作为Raf-1激酶抑制剂的研究及其基于结构研究的验证。
Bioorg Med Chem. 2004 Dec 15;12(24):6415-25. doi: 10.1016/j.bmc.2004.09.029.

引用本文的文献

1
New NADPH Oxidase 2 Inhibitors Display Potent Activity against Oxidative Stress by Targeting p22-p47 Interactions.新型NADPH氧化酶2抑制剂通过靶向p22 - p47相互作用对氧化应激显示出强大活性。
Antioxidants (Basel). 2023 Jul 18;12(7):1441. doi: 10.3390/antiox12071441.
2
A novel class of selective acetylcholinesterase inhibitors: synthesis and evaluation of (E)-2-(benzo[d]thiazol-2-yl)-3-heteroarylacrylonitriles.一类新型选择性乙酰胆碱酯酶抑制剂的合成与评价:(E)-2-(苯并[d]噻唑-2-基)-3-杂芳基丙烯腈的合成与评价。
Molecules. 2012 Oct 15;17(10):12072-85. doi: 10.3390/molecules171012072.
3
High throughput screening of a library based on kinase inhibitor scaffolds against Mycobacterium tuberculosis H37Rv.
基于激酶抑制剂支架的文库高通量筛选抗结核分枝杆菌 H37Rv。
Tuberculosis (Edinb). 2012 Jan;92(1):72-83. doi: 10.1016/j.tube.2011.05.005. Epub 2011 Jun 25.
4
Ligand-based and structure-based approaches in identifying ideal pharmacophore against c-Jun N-terminal kinase-3.基于配体和基于结构的方法在鉴定针对 c-Jun N-末端激酶-3 的理想药效团中的应用。
J Mol Model. 2011 Jan;17(1):151-63. doi: 10.1007/s00894-010-0701-0.